|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Transtuzumab in combination with chemotherapy for the treatment of metastatic breast cancer 显示文摘 | Fomier M Estera FJ Seidman AD | 2000 | Semin Oncol2000，27，11： | 1 |
| 2 | The safety of dose-dense doxorubicin and cyclophosphamide followed by paditaxel with trastuzumab in HER2/neu overexpressed/amplified breast cancer显示文摘 | Dang C Fomier M Sugaman S | 2008 | J Clin Oncol2008，26，： | 1 |
| 3 | The paradox of triple negative breast cancer: novel approaches to treatment 显示文摘 | Fomier M Fumoleau P | 2012 | Breast J2012，18，1： | 1 |
| 4 | Phase H clinicaltrial of ixabepilone (BMS-247550) ,an epothilone B ana-log ,in patients with taxane-resistant metastatic breast can-cqt显示文摘 | Thomas E Tabemero J Fomier M | 2007 | J Clin2007，25，23： | 1 |
| 5 | Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer显示文摘 | Fomier M Esteva FJ Seidman AD | 2000 | Semin Oncol2000，27，6： | 1 |
| 6 | Turn our markers CEA, NSE, SCC, TPA and CYFRA211 in respectable not small cell lung cancer 显示文摘 | Foa P Fomier M Miceli R | 1999 | Anticancer Res1999，19，4： | 1 |
| 7 | The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with tras- tuzumab in HER-2/neu overexpressed/amplified breast cancer 显示文摘 | Dang C Fomier M Sugarman S | 2008 | J Clin Oncol2008，28，8： | 1 |
| 8 | The paradox of triple negative breastcancer: novel approaches to treatment显示文摘 | Fomier M Fumoleau P | 2012 | Breast J2012，18，1： | 1 |
| 9 | Effect of long-term oral administration of β-glucan as an immunostimulant or an adjuvant on some non-specific parameters of the Lmmune response of turbot,Scophthalmus maximums显示文摘 | Debaulney M O Quental C Fomier V | 1996 | Dis Aquat Org1996，26，： | 1 |
| 10 | Tumourmarkers CEA,NSE,SCC,TPA and CYFRA21-1 in respectable nonsmall-cell lung cancer显示文摘 | Foa P Fomier M Miceli R | 1999 | Anticancer Res1999，19，4： | 1 |
| 11 | Tumour markers CEANSE, SCC,TPA and CYFRA 21-1 in respectable not small cell lung cancer显示文摘 | Foa P Fomier M Miceli R | 1999 | Anticancer Res1999，19，： | 1 |
| 12 | Tumor markers CEA,NSE,SCC,TPA and CYFRA21-1 in resectable non-small cell lung c ancer显示文摘 | Foa P Fomier M Miceli R | | 0，，4： | 1 |
| 13 | Tumour markers CEA NSE SCC TAP and CYFRA211 in respectable non small cell lung cancer显示文摘 | Fomier M Micel R | 1999 | Anticancer Res1999，19，4： | 1 |
| 14 | Phase Ⅱ clinical real of ixabepilone ( BMS-247550 ) , an epothilone B analog, in patients with taxane-resistant metastatic breast cancer显示文摘 | Thomas E Tabernero J Fomier M | 2007 | J Clin Oncol2007，25，23： | 1 |
| 15 | Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer 显示文摘 | Fomier M Esteva FJ Seidman AD | 2000 | Semin Oncol2000，27，611： | 1 |
| 16 | Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer 显示文摘 | Fomier M Esteva FJ Seidman AD | 2000 | Semin Oncul2000，27，611： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员